Andrew W B Craig (Andrew W Craig, A W Craig)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Scientific reports

British journal of cancer

Journal of medicinal chemistry

Oncoimmunology

Queen's University

McGill University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen's University Jul 01 2008

Canada

Associate Professor :: Biomedical and Molecular Sciences

Queen's University Jul 01 2002 - Jul 01 2008

Canada

Assistant Professor :: Biochemistry

Queen's University Mar 01 1998 - Jul 01 2002

Canada

Post-Doctoral Fellow :: Cancer Research Labs

Education History

McGill University May 01 1993 - Apr 01 1998

Canada

PHD :: Biochemistry

Queen's University Sep 01 1989 - May 01 1993

Canada

BSC :: Biochemistry

Publications

Andrew W B Craig, Hermann B Frieboes, Paula Alexendra Videira
Advancing cancer immunotherapy: from innovative preclinical models to clinical insights. Scientific reports 14 (1) (2024)
Daria N Trofimova, Madhu Aeluri, Kirana D Veeranna, Yun Jiang, Rebecca L Grange, Bhavin V Pipaliya, Murugan Subaramanian, Andrew W B Craig, P Andrew Evans, John S Allingham
Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness. Journal of medicinal chemistry (2024)
Andrew W B Craig, Hermann B Frieboes, Paula Alexendra Videira
Advancing cancer immunotherapy: from innovative preclinical models to clinical insights. Scientific reports 14 (1) (2024)
Andrew W B Craig, Hermann B Frieboes, Paula Alexendra Videira
Advancing cancer immunotherapy: from innovative preclinical models to clinical insights. Scientific reports 14 (1) (2024)
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W B Craig
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British journal of cancer 130 (12) (2024)
Daria N Trofimova, Madhu Aeluri, Kirana D Veeranna, Yun Jiang, Rebecca L Grange, Bhavin V Pipaliya, Murugan Subaramanian, Andrew W B Craig, P Andrew Evans, John S Allingham
Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness. Journal of medicinal chemistry 67 (7) (2024)
Andrew W B Craig, Hermann B Frieboes, Paula Alexendra Videira
Advancing cancer immunotherapy: from innovative preclinical models to clinical insights. Scientific reports 14 (1) (2024)
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W B Craig
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British journal of cancer (2024)
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W B Craig
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British journal of cancer 130 (12) (2024)
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W B Craig
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British journal of cancer 130 (12) (2024)
Daria N Trofimova, Madhu Aeluri, Kirana D Veeranna, Yun Jiang, Rebecca L Grange, Bhavin V Pipaliya, Murugan Subaramanian, Andrew W B Craig, P Andrew Evans, John S Allingham
Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness. Journal of medicinal chemistry (2024)
Daria N Trofimova, Madhu Aeluri, Kirana D Veeranna, Yun Jiang, Rebecca L Grange, Bhavin V Pipaliya, Murugan Subaramanian, Andrew W B Craig, P Andrew Evans, John S Allingham
Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness. Journal of medicinal chemistry (2024)
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C Vermeulen, Brian J Laight, Peter A Greer, Yan Lan, Andrew W B Craig
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British journal of cancer 130 (12) (2024)
Daria N Trofimova, Madhu Aeluri, Kirana D Veeranna, Yun Jiang, Rebecca L Grange, Bhavin V Pipaliya, Murugan Subaramanian, Andrew W B Craig, P Andrew Evans, John S Allingham
Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness. Journal of medicinal chemistry 67 (7) (2024)
J L MacKeil, P Brzezinska, Jonah Burke-Kleinman, Andrew W B Craig, C J B Nicol, D H Maurice
A PKA/cdc42 Signaling Axis Restricts Angiogenic Sprouting by Regulating Podosome Rosette Biogenesis and Matrix Remodeling. Scientific reports 9 (1) (2019)
Stephanie Young, Namit Sharma, Jae Hoon Lee, Violeta Chitu, Volker Neumeister, Elisabeth Sohr, E Richard Stanley, Christian M Hedrich, Andrew W B Craig
Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis. Disease models & mechanisms 12 (8) (2019)
Sarah Nersesian, Rodette Williams, Daniel Newsted, Kavan Shah, Stephanie Young, P Andrew Evans, John S Allingham, Andrew W B Craig
Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis. Scientific reports 8 (1) (2018)
Daniel Newsted, Sunandan Banerjee, Kathleen Watt, Sarah Nersesian, Peter Truesdell, Levi L Blazer, Lia Cardarelli, Jarrett J Adams, Sachdev S Sidhu, Andrew W B Craig
Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models. Oncoimmunology 8 (2) (2018)

Andrew W B Craig.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew W Craig, A W Craig)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew W B Craig (Andrew W Craig, A W Craig)